A new vaccine against advanced cutaneous melanoma will be available to UK patients through an NHS program
Sanziana Georgescu
Health
sursa foto: pexels.com
Always see our news on Google
<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
23:00
Iran threatens neighboring states / Iranian airlines’ flights canceled after new U.S. sanctions
22:50
The European Commission proposes unlocking €4.2 billion for Hungary
22:43
Siegfried Mureșan explains why he did not go to the PSD headquarters for the meeting with Sorin Grindeanu
22:41
Nicușor Dan presented an account of his visit to the UN: discussions on investments from the US, meetings with American officials, and meetings with members of the Romanian community
22:37
Rareș Bogdan recommends that the lawmakers of the Liberal-Conservative Platform within the PNL vote for the “undercover Bolojan Government 2”
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
